PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Update

PURE Bioscience, Inc. (OTCMKTS:PURE) saw a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 400 shares, a decrease of 97.2% from the November 15th total of 14,500 shares. Based on an average daily trading volume, of 46,900 shares, the days-to-cover ratio is presently 0.0 days.

PURE Bioscience Stock Up 11.1 %

OTCMKTS PURE traded up $0.01 during trading hours on Friday, reaching $0.07. The company’s stock had a trading volume of 52,615 shares, compared to its average volume of 29,677. PURE Bioscience has a 52 week low of $0.06 and a 52 week high of $0.16. The firm has a fifty day simple moving average of $0.09 and a 200-day simple moving average of $0.08.

PURE Bioscience (OTCMKTS:PURE) last released its quarterly earnings results on Tuesday, October 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The firm had revenue of $0.47 million for the quarter.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.